BioMark Diagnostics, Inc.: BioMark Receives $825K Grant to Develop Its Liquid Biopsy Assay for Lung Cancer Screening
Vancouver, British Columbia--(Newsfile Corp. - June 1, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce today that its wholly-owned subsidiary
United Kingdom British Columbia Philippe Joubert Rashid Ahmed Bux Quebec Respiratory Health Research Network Innovation In Medical Technology
Source: finanznachrichten.de